Abstract
The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first-line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.
Cite
CITATION STYLE
Cicek-Saydam, C., Cavusoglu, C., Burhanoglu, D., Hilmioglu, S., Ozkalay, N., & Bilgic, A. (2001). In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid. Clinical Microbiology and Infection, 7(12), 700–702. https://doi.org/10.1046/j.1469-0691.2001.00341.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
